Exponent sees FY24 revenue up low to mid-single digits

For the fiscal year 2024 we are raising our revenue and margin guidance. Exponent anticipates: Revenues before reimbursements to grow in the low to mid-single digits; and, EBITDA1 to be 27.5% to 28.0% of revenues before reimbursements. “Exponent thrives in the complexity that abounds in products, technologies and regulations. In this environment of relentless innovation in safety-critical applications, we are focused on fueling the growth engines of the future through expanded capabilities, recruitment of top talent, and development of our exceptional team,” Dr. Corrigan concluded.